Zomedica reports record FY 2023 revenue $25.2M (+33% YoY); net loss $34.5M; guides FY 2024 revenue $31-35M

Zomedica Corp.

2024-Q1 EPS reported -$0.01 revenue$6,262,000

Q4 2023 revenue $7.3M (+19% YoY); full-year revenue $25.2M vs $18.9M in 2022.
Gross margin 69% for both Q4 and full year 2023; consumable revenue grew 41% to $16.4M.
Net loss $34.5M ($0.035 per share) vs $17.0M ($0.017) in 2022; adjusted non-GAAP EBITDA loss $12.8M.
Cash and securities $100.5M as of Dec 31, 2023; operating cash burn adjusted for one-time items ~$2.6M in Q4.
FY 2024 revenue guidance $31-35M (up to 40% YoY); growth driven by recent product launches and acquisitions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Zomedica Corp. reported the fourth quarter ended December 31, 2023 results: revenue $7.3 million.

Period: the fourth quarter ended December 31, 2023
Revenue: $7.3 million
Result: reported results

Exact text from the filing

Revenue for the fourth quarter of 2023 grew 19% to $7.3 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Zomedica Corp. reported the year ended December 31, 2023 results: revenue $25.2 million.

Period: the year ended December 31, 2023
Revenue: $25.2 million
Result: reported results

Exact text from the filing

X-99.1 2 zom_ex991.htm PRESS RELEASE zom_ex991.htm EXHIBIT 99.1 Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Zomedica Corp. reported full year 2024 results: revenue $31 to $35 million. Guidance reaffirmed.

Period: full year 2024
Revenue: $31 to $35 million
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Zomedica continues to expect full year revenue in the range of $31 to $35 million

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Zomedica Corp. filing history →

Source: SEC EDGAR

accession 0001654954-24-004239

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.